Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Prostate Cancer

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 42 articles: HTML format Text format

Single Articles

January 2012
1. EWING CM , Ray AM, Lange EM, Zuhlke KA, et al
   Germline mutations in HOXB13 and prostate-cancer risk.
   N Engl J Med. 2012;366:141-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. KIM J , Amos CI, Logothetis C
   5alpha-Reductase inhibitors for prostate-cancer prevention.
   N Engl J Med. 2011;365:2340.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
3. MCNAUGHTON-COLLINS MF , Barry MJ
   One man at a time--resolving the PSA controversy.
   N Engl J Med. 2011;365:1951-3.
   PubMed     Text format     Related articles   
   
   
   
   October 2011
4. BRETT AS , Ablin RJ
   Prostate-Cancer Screening - What the U.S. Preventive Services Task Force Left Out.
   N Engl J Med. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SCHRODER FH
   Stratifying Risk - The U.S. Preventive Services Task Force and Prostate-Cancer Screening.
   N Engl J Med. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. HOFFMAN RM
   Screening for Prostate Cancer.
   N Engl J Med. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. CREHANGE G , Bolla M, Maingon P
   Radiotherapy and androgen deprivation for prostate cancer.
   N Engl J Med. 2011;365:1354.
   PubMed     Text format     Related articles   
   
   
   
   August 2011
8. 
   Abiraterone and Increased Survival in Metastatic Prostate Cancer.
   N Engl J Med. 2011;365:766-768.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. BERRUTI A , Pia A, Terzolo M
   Abiraterone and Increased Survival in Metastatic Prostate Cancer.
   N Engl J Med. 2011;365:766-768.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. SONPAVDE G
    Abiraterone and Increased Survival in Metastatic Prostate Cancer.
    N Engl J Med. 2011;365:766-768.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. PARKER C , Sartor O
    Abiraterone and Increased Survival in Metastatic Prostate Cancer.
    N Engl J Med. 2011;365:766-768.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. FROEHNER M , Wirth MP
    Early prostate cancer--treat or watch?
    N Engl J Med. 2011;365:568.
    PubMed     Text format     Related articles   
    
    
    
    
13. SHIGETA K , Naito Y, Takano T
    Early prostate cancer--treat or watch?
    N Engl J Med. 2011;365:568-9.
    PubMed     Text format     Related articles   
    
    
    
    
14. KLOTZ L , Thompson I
    Early prostate cancer--treat or watch?
    N Engl J Med. 2011;365:569.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
15. D'AMICO AV
    Risk-based management of prostate cancer.
    N Engl J Med. 2011;365:169-71.
    PubMed     Text format     Related articles   
    
    
    
    
16. JONES CU , Hunt D, McGowan DG, Amin MB, et al
    Radiotherapy and short-term androgen deprivation for localized prostate cancer.
    N Engl J Med. 2011;365:107-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
17. THEORET MR , Ning YM, Zhang JJ, Justice R, et al
    The Risks and Benefits of 5alpha-Reductase Inhibitors for Prostate-Cancer Prevention.
    N Engl J Med. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
18. ANTONARAKIS ES , Eisenberger MA
    Expanding treatment options for metastatic prostate cancer.
    N Engl J Med. 2011;364:2055-8.
    PubMed     Text format     Related articles   
    
    
    
    
19. SMITH MR , Zietman AL, Finkelstein JS, Wu CL, et al
    Case records of the Massachusetts General Hospital. Case 16-2011. A 67-year-old man with recurrent prostate cancer.
    N Engl J Med. 2011;364:2044-51.
    PubMed     Text format     Related articles   
    
    
    
    
20. DE BONO JS , Logothetis CJ, Molina A, Fizazi K, et al
    Abiraterone and increased survival in metastatic prostate cancer.
    N Engl J Med. 2011;364:1995-2005.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SMITH MR
    Effective treatment for early-stage prostate cancer--possible, necessary, or both?
    N Engl J Med. 2011;364:1770-2.
    PubMed     Text format     Related articles   
    
    
    
    
22. BILL-AXELSON A , Holmberg L, Ruutu M, Garmo H, et al
    Radical prostatectomy versus watchful waiting in early prostate cancer.
    N Engl J Med. 2011;364:1708-17.
    PubMed     Text format     Related articles   
    
    
    
    
23. CHAMBERS JD , Neumann PJ
    Listening to Provenge--what a costly cancer treatment says about future Medicare policy.
    N Engl J Med. 2011;364:1687-9.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
24. KAUFMAN DS , Zietman AL, Dahl DM, Harisinghani MG, et al
    Case records of the Massachusetts General Hospital. Case 5-2011. A 65-year-old man with hematuria after treatment for prostate cancer.
    N Engl J Med. 2011;364:667-75.
    PubMed     Text format     Related articles   
    
    
    
    
25. 
    Reimbursement policy and androgen-deprivation therapy for prostate cancer.
    N Engl J Med. 2011;364:579-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. WAGLE DG
    Reimbursement policy and androgen-deprivation therapy for prostate cancer.
    N Engl J Med. 2011;364:579-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. ARAGON-CHING JB
    Reimbursement policy and androgen-deprivation therapy for prostate cancer.
    N Engl J Med. 2011;364:579-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
28. AWAD MM , Fleshman JW
    Robot-assisted surgery and health care costs.
    N Engl J Med. 2010;363:2174-5.
    PubMed     Text format     Related articles   
    
    
    
    
29. CRAWFORD ED , Rove KO
    Incomplete testosterone suppression in prostate cancer.
    N Engl J Med. 2010;363:1976.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. 
    Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
    N Engl J Med. 2010;363:1966-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. TANIMOTO T , Hori A, Kami M
    Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
    N Engl J Med. 2010;363:1966-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. NABHAN C
    Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
    N Engl J Med. 2010;363:1966-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. SHAHINIAN VB , Kuo YF, Gilbert SM
    Reimbursement policy and androgen-deprivation therapy for prostate cancer.
    N Engl J Med. 2010;363:1822-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
34. RADU A , Pichon C, Camparo P, Antoine M, et al
    Expression of follicle-stimulating hormone receptor in tumor blood vessels.
    N Engl J Med. 2010;363:1621-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
35. LEE HL
    Images in clinical medicine. Radiation proctitis.
    N Engl J Med. 2010;363:1163.
    PubMed     Text format     Related articles   
    
    
    
    August 2010
36. 
    Dutasteride and prostate cancer.
    N Engl J Med. 2010;363:793-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. KLOTZ L
    Dutasteride and prostate cancer.
    N Engl J Med. 2010;363:794.
    PubMed     Text format     Related articles   
    
    
    
    
38. GARATTINI S , Bertele' V
    Dutasteride and prostate cancer.
    N Engl J Med. 2010;363:794.
    PubMed     Text format     Related articles   
    
    
    
    
39. SCHRODER FH , Roobol MJ
    Dutasteride and prostate cancer.
    N Engl J Med. 2010;363:793-4.
    PubMed     Text format     Related articles   
    
    
    
    
40. BARBASH GI , Glied SA
    New technology and health care costs--the case of robot-assisted surgery.
    N Engl J Med. 2010;363:701-4.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
41. LONGO DL
    New therapies for castration-resistant prostate cancer.
    N Engl J Med. 2010;363:479-81.
    PubMed     Text format     Related articles   
    
    
    
    
42. KANTOFF PW , Higano CS, Shore ND, Berger ER, et al
    Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
    N Engl J Med. 2010;363:411-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: